Test performance, CalproLab (ALP)
Note: All design verification studies were performed on faeces extract samples (diluted 1:100) or EDTA plasma samples (diluted 1:20), using the ELISA procedure described in the kit package insert.
Inter-assay precision, faeces extracts
Mean results from three different laboratories, each testing two different kit lots: six samples were tested a total of 10 times over five days:
|
Concentration (ng/mL) |
Concentration (mg/kg) |
%CV |
|
6.4 |
32.1 |
13 |
|
34.1 |
171 |
6.0 |
|
73.7 |
368 |
4.8 |
|
117 |
583 |
6.1 |
|
243 |
1215 |
6.8 |
|
395 |
1977 |
7.9 |
Intra-assay precision, faeces extracts
Mean results from three different laboratories, each testing two kit lots: six samples were tested with 10 replicates in one run:
|
Concentration (ng/mL) |
Concentration (mg/kg) |
%CV |
|
5.7 |
28.7 |
6.7 |
|
34.5 |
173 |
3.6 |
|
77.1 |
385 |
4.1 |
|
118 |
592 |
4.0 |
|
242 |
1210 |
4.2 |
|
393 |
1966 |
5.0 |
Intra-assay precision, EDTA plasma
Tested using one kit lot; six samples were diluted 1:20 and tested with 10 replicates in one run:
|
Concentration (ng/mL) |
Concentration (x 20) |
%CV |
|
8.3 |
166 |
3.8 |
|
37 |
740 |
4.7 |
|
58 |
1160 |
2.9 |
|
68 |
1360 |
3.5 |
|
149 |
2980 |
3.2 |
|
183 |
3660 |
10 |
Recovery
Faeces: 85 – 105%; tested with faecal extract spiked with purified Calprotectin at five different levels.
Plasma: 81 – 105%; tested with plasma spiked with purified Calprotectin at five different levels.
Limit of Quantification:
5 ng/mL; tested with faeces extract, plasma and purified Calprotectin. Samples were analysed five times over five days. The mean CV for the different samples and determinations at this level was 12%.
Limit of Detection:
< 5 ng/mL; calculated as mean (Sample Dilution Buffer; n= 32) + 5x SD.
Agreement with Calpro Calprotectin ELISA CAL0100
Satisfactory correlation and agreement has been found between samples analysed in CAL0100 and in CALP0170:
Faeces extracts: R² = 0.792 (48 – 1250 mg/kg, n=118 samples), R² = 0.864 (48 – 500 mg/kg, n=85 samples)
Plasma: R² = 0.977 (260 – 6400 µg/L, n=16 samples)
Interference
No observed interference on the ELISA from commonly used pharmaceuticals: Prednisolon, Imurel, Salazopyrin and Ciprofloaxcin.
Extraction precision
Two faeces samples were extracted 10 times each, using the procedure described in section 7.1.1, and the extracts analysed in the ELISA. Mean results from three different laboratories and one kit lot:
|
Sample |
Concentration (mg/kg) |
%CV |
|
Low |
130 |
8.7 |
|
High |
1357 |
8.8 |
Linearity, faecal extracts
Faecal extracts (n=10) were diluted 1:100 – 1:1000 and analysed in the ELISA. Mean results:
|
Dilution |
% of 1:100 dilution |
|
1:100 |
100 |
|
1:400 |
103 |
|
1:700 |
105 |
|
1:1000 |
107 |
Note that sample variation in linearity has been observed.
Linearity, EDTA plasma
Plasma samples (n=5) were diluted 1:20 – 1:80 and analysed in the ELISA. Mean results:
|
Dilution |
% of 1:20 dilution |
|
1:20 |
100 |
|
1:40 |
107 |
|
1:80 |
116 |
Note that sample variation in linearity has been observed.
Next page: KIT CONTENT/ INSTRUCTIONS Previous page: CalproLab™ ELISA (ALP) Intended use


